Credit Suisse’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-126,229
| Closed | -$2.74M | – | 3781 |
|
|
2017
Q2 | $2.74M | Buy |
126,229
+94,039
| +292% | +$2.04M | ﹤0.01% | 1713 |
|
|
2017
Q1 | $452K | Sell |
32,190
-19,317
| -38% | -$271K | ﹤0.01% | 2990 |
|
|
2016
Q4 | $966K | Sell |
51,507
-55,266
| -52% | -$1.04M | ﹤0.01% | 2718 |
|
|
2016
Q3 | $1.76M | Buy |
106,773
+70,976
| +198% | +$1.17M | ﹤0.01% | 2182 |
|
|
2016
Q2 | $481K | Buy |
35,797
+21,012
| +142% | +$282K | ﹤0.01% | 3152 |
|
|
2016
Q1 | $226K | Sell |
14,785
-42,784
| -74% | -$654K | ﹤0.01% | 3342 |
|
|
2015
Q4 | $1.14M | Buy |
57,569
+39,642
| +221% | +$786K | ﹤0.01% | 2513 |
|
|
2015
Q3 | $313K | Sell |
17,927
-115,467
| -87% | -$2.02M | ﹤0.01% | 3479 |
|
|
2015
Q2 | $2.7M | Buy |
133,394
+85,518
| +179% | +$1.73M | ﹤0.01% | 2094 |
|
|
2015
Q1 | $843K | Sell |
47,876
-7,595
| -14% | -$134K | ﹤0.01% | 2878 |
|
|
2014
Q4 | $904K | Buy |
55,471
+27,091
| +95% | +$441K | ﹤0.01% | 2888 |
|
|
2014
Q3 | $627K | Sell |
28,380
-13,771
| -33% | -$304K | ﹤0.01% | 3086 |
|
|
2014
Q2 | $849K | Sell |
42,151
-12,956
| -24% | -$261K | ﹤0.01% | 3024 |
|
|
2014
Q1 | $1.02M | Sell |
55,107
-179,187
| -76% | -$3.33M | ﹤0.01% | 2768 |
|
|
2013
Q4 | $2.36M | Buy |
234,294
+161,514
| +222% | +$1.63M | ﹤0.01% | 2179 |
|
|
2013
Q3 | $938K | Buy |
72,780
+8,017
| +12% | +$103K | ﹤0.01% | 2628 |
|
|
2013
Q2 | $769K | Buy |
+64,763
| New | +$769K | ﹤0.01% | 2632 |
|